The updated 2024–2025 COVID-19 and influenza recommendations are quite straightforward – everyone 6 months or older should get the updated COVID-19 vaccine and, in most cases, the flu vaccine, including pregnant women.
CDC recommends everyone ages 6 months and older receive an updated 2024-2025 COVID-19 vaccine to protect against the potentially serious outcomes of COVID-19 this fall and winter whether or not they have ever previously been vaccinated with a COVID-19 vaccine. Updated COVID-19 vaccines will be available from Moderna, Novavax, and Pfizer later this year. This recommendation will take effect as soon as the new vaccines are available.
Children 6 months to 8 years old receiving their first influenza vaccine, who have not previously received a total of two or more doses in their lives, or whose influenza vaccination history is unknown need two doses.
In adults 65 or older, the CDC recommends a higher dose flu vaccine or adjuvanted flu vaccine over standard-dose unadjuvanted flu vaccines, if available. Most people need only one dose of the flu vaccine each season. September and October remain the best times for most people to get vaccinated.
RSV. For RSV, all infants under 8 months as well as children 8 months–19 months with risk factors should get the monoclonal antibody nirsevimab, whichis typically given October through March. There is also a maternal RSV vaccine, which is recommended during pregnancy between 32- and 36-weeks’ gestation. This is typically given September through January. Patients who are pregnant should only get the ABRYSVO vaccine manufactured by Pfizer.
All adults 75 or older, as well as adults 60 through 74 who are at increased risk for severe RSV, are recommended to get the RSV vaccine. Risk factors for severe RSV include underlying conditions such as obesity, diabetes, heart or lung disease, or living in a nursing home, where CDC is seeing more RSV circulating this season. One dose of RSV vaccine provides protection against RSV disease in adults ages 60 years and older for at least two years.
RSV vaccines are 70% and 90% effective in preventing hospitalizations in older adults and infants, respectively. More information about RSV side effects and safety information is available: https://www.cdc.gov/vaccine-safety/vaccines/rsv.html
Source: https://www.cdc.gov/media/releases/2024/s-t0627-vaccine-recommendations.html
